Vestmark Advisory Solutions’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Vestmark Advisory Solutions's ELV Position: Q2 2026 in Review
Vestmark Advisory Solutions increased its Elevance Health (ELV) stake by 35% in Q2 2026, buying an estimated $414K and bringing the position to 4,325 shares worth $1.67M. The position accounts for 0.02% of the portfolio, ranked #782.
Vestmark Advisory Solutions first reported a position in ELV in Q1 2019 and has held it in 22 quarters since. The position peaked at $3.31M in Q2 2023. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Vestmark Advisory Solutions held 4,325 shares of Elevance Health worth $1.67M as of Q2 2026.
- Vestmark Advisory Solutions bought 1,116 Elevance Health shares in Q2 2026, an estimated $414K.
- Elevance Health made up 0.02% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #782 holding.
- Vestmark Advisory Solutions first reported a position in Elevance Health in Q1 2019 and has held it in 22 quarters since.
- Vestmark Advisory Solutions's Elevance Health position peaked at $3.31M in Q2 2023.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.